APA (7th ed.) Citation

Park, S. Y., Jeong, K. J., Poire, A., Zhang, D., Tsang, Y. H., Blucher, A. S., & Mills, G. B. (2023). Irreversible HER2 inhibitors overcome resistance to the RSL3 ferroptosis inducer in non-HER2 amplified luminal breast cancer. Cell death & disease, 14(8), 532-12. https://doi.org/10.1038/s41419-023-06042-1

Chicago Style (17th ed.) Citation

Park, Soon Young, Kang Jin Jeong, Alfonso Poire, Dong Zhang, Yiu Huen Tsang, Aurora S. Blucher, and Gordon B. Mills. "Irreversible HER2 Inhibitors Overcome Resistance to the RSL3 Ferroptosis Inducer in Non-HER2 Amplified Luminal Breast Cancer." Cell Death & Disease 14, no. 8 (2023): 532-12. https://doi.org/10.1038/s41419-023-06042-1.

MLA (9th ed.) Citation

Park, Soon Young, et al. "Irreversible HER2 Inhibitors Overcome Resistance to the RSL3 Ferroptosis Inducer in Non-HER2 Amplified Luminal Breast Cancer." Cell Death & Disease, vol. 14, no. 8, 2023, pp. 532-12, https://doi.org/10.1038/s41419-023-06042-1.